Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-19

Clinical Trial Update: Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating desloratadine for persistent allergic rhinitis (Study P04684) has completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2010-11-19